NEWS
See the latest PIR International News, Articles and Network Updates.
PIR International Supports Appointment of Chairman at Sibylla Biotech
PIR International was delighted to partner with Lidia Pieri and the Board at Sibylla Biotech on the appointment of Dieter Weinand as Chairman of the Board of Directors. Sibylla is a preclinical stage company focused on developing small molecule degraders [...]
PIR International Supports Appointment of Chair and Non-Executive Director at PhoreMost
PIR International was delighted to partner with Dr Neil Torbett and the Board at PhoreMost on the appointment of Barbara Duncan as Chair and Stephen Dilly as Non-Executive Director. PhoreMost is a UK-based biopharmaceutical company pioneering next-generation drug discovery through [...]
PIR International Supports Appointment of Chair and Advisory Board Member at Monument Therapeutics
PIR International is pleased to announce the appointment of Robert (Bob) Radie as Non-Executive Chair and Heather Preston as Advisory Board Member at Monument Therapeutics. Monument Therapeutics is a neuroscience-focused drug development company headquartered in Manchester, UK. It applies a [...]
Paul Sekhri – BioLeader Interview
President & Chief Executive Officer, vTv Therapeutics (February 2025) Paul Sekhri has over 35 years of experience in the Life Science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity [...]